I-MAB |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.575 EUR | -0.94% |
|
-1.26% | -4.85% |
| 06-06 | I-Mab Appoints Phillip Dennis as Chief Medical Officer | CI |
| 06-05 | I-Mab Collaborates With Bristol-Myers to Evaluate Givastomig in Combination Study for Gastric, Esophageal Cancers | MT |
Quotes 5-day view
Delayed Quote Deutsche Boerse AG| 21/06/2024 | 24/06/2024 | 25/06/2024 | 26/06/2024 | 27/06/2024 | |
|---|---|---|---|---|---|
| Last | 1.56 € | 1.55 € | 1.58 € | 1.59 € | 1.57 € |
| Volume | 0 | 0 | 0 | 0 | 0 |
| Change | -1.89% | -0.64% | +1.94% | +0.63% | -0.94% |
| Opening | 1.56 | 1.55 | 1.58 | 1.59 | 1.57 |
| High | 1.56 | 1.55 | 1.58 | 1.59 | 1.57 |
| Low | 1.56 | 1.55 | 1.58 | 1.59 | 1.57 |
Performance
| 1 day | -0.94% | ||
| 1 week | -1.26% | ||
| Current month | -1.26% | ||
| 1 month | -1.26% | ||
| 3 months | -7.10% | ||
| 6 months | +10.56% | ||
| Current year | -4.85% | ||
| 1 year | -43.53% | ||
| 3 years | -97.60% |
Volumes
marketsCapital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (EUR)
137 596 214
Capitalization (USD)
137 596 214
Net sales (USD)
3 893 000
Number of employees
220
Sales / Employee (USD)
17 695
Free-Float
84.84 %
Free-Float capitalization (EUR)
292 593 495
Free-Float capitalization (USD)
273 272 961
Average Daily Capital Traded
0%
Highs and lows
1 week
1.55
1.59
1 month
1.431.75
Current year
1.392.14
1 year
1.092.80
3 years
1.0972.50
5 years
1.0972.50
10 years
1.0972.50
Indicators
Moving average 5 days
1.57
Moving average 20 days
1.64
Moving average 50 days
1.64
Moving average 100 days
1.64
Price spread / (MMA5)
-0.06%
Price spread / (MMA20)
+3.84%
Price spread / (MMA50)
+4.13%
Price spread / (MMA100)
+3.81%
STIM
RSI 9 days
41.06
RSI 14 days
44.08
Sector Comparison - Other Pharmaceuticals
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| -0.94% | -1.26% | -4.85% | -43.53% | 138M | ||
| +0.39% | +2.10% | +55.19% | +94.75% | 811B | ||
| -0.44% | +0.89% | +43.62% | +90.61% | 640B | ||
| -0.89% | -1.85% | -7.46% | -11.17% | 353B | ||
| -1.93% | -1.04% | +17.70% | +13.24% | 333B | ||
| -1.50% | -1.99% | +8.86% | +27.22% | 302B | ||
| -1.82% | -0.56% | +16.30% | +10.17% | 246B | ||
| +0.32% | +0.16% | +2.41% | -7.48% | 225B | ||
| -0.50% | +1.19% | +12.47% | +7.59% | 218B | ||
| -0.16% | +0.70% | +8.35% | +40.18% | 168B | ||
| +1.40% | +0.05% | -3.59% | -23.79% | 155B | ||
| -1.02% | +1.99% | +0.11% | -8.20% | 121B | ||
| -0.68% | +0.42% | -15.10% | -9.51% | 86.35B | ||
| -1.94% | +1.56% | -18.77% | -35.63% | 86.15B | ||
| -4.60% | -5.69% | +5.23% | +8.83% | 82.34B | ||
| -2.58% | +3.17% | +42.20% | +19.83% | 67.24B | ||
| Average | -1.02% | +2.42% | +10.17% | +10.82% | ||
| Weighted average by Cap. | -0.62% | +1.76% | +22.36% | +37.54% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Monthly variations
Annual change
| 2024 | -3.64% | ||
| 2023 | -50.60% | ||
| 2022 | -91.69% | ||
| 2021 | +21.82% | ||
| 2020 | +184.48% |
- Stock Market
- Equities
- IMAB Stock
- 0VY Stock
- Quotes I-Mab
